Phage therapy future
Following a high-profile success in 2016, the field of phage therapy has been reinvigorated. Numerous biotechnology companies, academic groups, and hospitals are now developing and using phage to treat bacterial infections.
Recently, several clinical trials and many personalized medical applications of phage have failed.
Because of a lack of basic science, the reasons behind when and why phage therapy for infections fails, indeed when and why it succeeds, are not understood.
The regulatory framework governing the use of phage for the treatment of infections is not amenable to the development and expansion of phage therapy.
https://www.cell.com/trends/molecular-medicine/fulltext/S1471-4914(25)00084-X
